What is LOPJLB’s current signal on LTGO?

LOPJLB’s latest quantitative signal on Latigo Biotherapeutics Inc. (LTGO) is SELL. Signals are updated daily.

What market regime is LTGO in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does Latigo Biotherapeutics Inc. (LTGO) do?

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquarte…

Where is Latigo Biotherapeutics Inc. based / listed?

Latigo Biotherapeutics Inc. is based in US, listed on NASDAQ.

Latigo Biotherapeutics Inc. (LTGO)

COMPARE

Healthcare · Medical - Pharmaceuticals · NASDAQ · US

$15.52-4.55%Close

SELL

[SCORES & PROFILE]

FUND: 0
VALUE: 0
GROWTH: 0
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-

---

[VALUATION]

P/E TTM-

P/E FWD-

SECTOR PE20.33

INDUSTRY PE106.69

P/B-

P/FCF-

EV/EBITDA-

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO-

ND/EBITDA-

BETA0.00

Latigo Biotherapeutics Inc. (LTGO)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news